Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

45

Revenue 2017

Zytiga

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Zytiga was produced by Janssen.

Xtandi on course for pre-chemo use in prostate cancer

Xtandi on course for pre-chemo use in prostate cancer the drug's take-up as it competes in the market against Johnson &Johnson's Zytiga (abiraterone). ... It was also approved in Japan in March. Zytiga reached the market a few months ahead of Xtandi and has quickly become a big seller for J&J, with sales of

Print health ad spend in US remains buoyant

Print health ad spend in US remains buoyant Kantar's research indicates that print is still a main choice for pharma, however, with Johnson &Johnson's £3.3m January spend included advertisements for prostate cancer treatment Zytiga, the blood

Mixed cancer news from NICE

Mixed cancer news from NICE The agency's main issue was the Bayer did not provide data that compared Xofigo to other recommended treatments, namely the chemotherapy docetaxel and Janssen's Zytiga (abiraterone).

Xtandi filed as pre-chemo prostate cancer therapy

Xtandi filed as pre-chemo prostate cancer therapy If approved, that profile bodes well for Xtandi as it competes in the marketplace against Johnson &Johnson's CRPC therapy Zytiga (abiraterone acetate), which reached the market a few months earlier ... Zytiga was approved for use in chemotherapy-naïve

Pharma's winners and losers in 2013

Pharma's winners and losers in 2013 Johnson &Johnson also had a very strong year in pharma sales, with eight of its key products, including anticoagulant Xarelto (rivaroxaban), Zytiga (abiraterone) for prostate cancer, arthritis drug Stelara (ustekinumab) and

[ Previous 5 results ] 8 9 10 11 12 13 14 15 16 17 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
Serious about sustainability?
Get to know our new Sustainability Officer here at Cuttsy+Cuttsy...
How scientific storytelling can help Pharma cut through the noise
Rather than being afraid of storytelling, pharmaceutical firms should be embracing it. Because what scientific storytelling allows us to do is to communicate quickly and efficiently. It provides a shortcut...